Brind.
  1. Emergent BioSolutions secured seven biodefense contract modifications from the U.S. Government.

SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.

3 reports, 3 independent Updated Aug 7
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.

Who's involved

What this event is mainly about
SIGA Technologies

Keep exploring

Part of

Emergent BioSolutions secured seven biodefense contract modifications from the U.S. Government. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • yahoo.com
  • GlobeNewswireSIGA Reports Financial Results for Three and Six Months Ended June 30, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30 Aw
  • GuruFocus.comSIGA Technologies Inc (SIGA) Q2 2025 Earnings Call Highlights: Strong Revenue and Strategic ... Product Revenue: $79 million for Q2 2025, including $53 million from oral TPOXX and $26 million from IV